Breakthrough in Type 1 Diabetes Therapy with Autologous Islet Transplant
Author Information
Author(s): Wang S, Abou Zaki Ram, El-Osta Assam
Primary Institution: Nankai University
Hypothesis
Can chemically induced pluripotent stem-cell-derived islets provide long-term insulin independence for type 1 diabetes patients?
Conclusion
The study demonstrated that a patient achieved stable insulin independence for over a year following the transplantation of autologous islets derived from her own stem cells.
Supporting Evidence
- The patient achieved complete insulin freedom at day 75 post-surgery.
- Fasting blood glucose levels improved from 210 ± 59 mg/dL to 126 mg/dL after surgery.
- Patient time-in-range increased from 43.18% to over 98% during follow-up.
- HbA1c levels dropped from 7.57% to 5.37% by day 120.
Takeaway
A patient with type 1 diabetes received a transplant of her own stem cells turned into insulin-producing cells and was able to stop taking insulin for a whole year.
Methodology
The study involved autologous transplantation of chemically induced pluripotent stem-cell-derived islets into a patient, with a focus on minimizing immune rejection.
Limitations
The treatment is still in early stages and not yet ready for widespread use.
Participant Demographics
The participant was a 25-year-old female with type 1 diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website